Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination

被引:159
作者
Cohen, Bernard J. [1 ]
Audet, Susette [2 ]
Andrews, Nick [1 ]
Beeler, Judy [2 ]
机构
[1] Hlth Protect Agcy, Ctr Infect, London NW9 5EQ, England
[2] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
measles; plaque reduction neutralization test;
D O I
10.1016/j.vaccine.2007.10.046
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Clinical trials of measles vaccination administered as aerosol are planned with the aim of obtaining Licensure. Measles antibody Levels wilt be measured using the plaque reduction neutralization test (PRNT) to assess antibody responses as a surrogate marker of efficacy. Methods: A working group examined laboratory protocols for measles PRNT in use at three reference centres and agreed to a standardised procedure, which was subsequently validated. Results: Assay validation showed quantitative results varied approximately threefold both within and between assays. The lower limit of detection was approximately 20 milliInternational Units/mL.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 20 条
[1]   ROLE OF VIRUS-STRAIN IN CONVENTIONAL AND ENHANCED MEASLES PLAQUE NEUTRALIZATION TEST [J].
ALBRECHT, P ;
HERRMANN, K ;
BURNS, GR .
JOURNAL OF VIROLOGICAL METHODS, 1981, 3 (05) :251-260
[2]  
[Anonymous], 2001, FIELDS VIROLOGY
[3]   Factors determining prevalence of maternal antibody to measles virus through infancy:: A review [J].
Cáceres, VM ;
Strebel, PM ;
Sutter, RW .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) :110-119
[4]  
CHEN R, 1986, 35 ANN EP INT SERV C
[5]   MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS [J].
CHEN, RT ;
MARKOWITZ, LE ;
ALBRECHT, P ;
STEWART, JA ;
MOFENSON, LM ;
PREBLUD, SR ;
ORENSTEIN, WA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1036-1042
[6]   Measles immunity testing: Comparison of two measles IgG ELISAs with plaque reduction neutralisation assay [J].
Cohen, BJ ;
Parry, RP ;
Doblas, D ;
Samuel, D ;
Warrener, L ;
Andrews, N ;
Brown, D .
JOURNAL OF VIROLOGICAL METHODS, 2006, 131 (02) :209-212
[7]  
*EUR MED AG CHMP, 2005, CHMPVWP1646532005
[8]   THE 1ST INTERNATIONAL STANDARD FOR ANTI-MEASLES SERUM [J].
FORSEY, T ;
HEATH, AB ;
MINOR, PD .
BIOLOGICALS, 1991, 19 (03) :237-241
[9]   Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States [J].
Gans, HA ;
Yasukawa, LL ;
Alderson, A ;
Rinki, M ;
DeHovitz, R ;
Beeler, J ;
Audet, S ;
Maldonado, Y ;
Arvin, AM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :83-90
[10]  
GRIST NR, 1996, DIAGNOSTIC METHODS C